On Thursday 31st October 2024, investors and market participants can expect the release of Agios Pharmaceuticals (NASDAQ: AGIO) third quarter financial results. This crucial announcement will be made before market open.
As per the projections made by financial experts on Wall Street, the concern is expected to announce an estimated $1.11 profit per share for the quarter. Moreover, the firm is likely to disclose a quarterly revenue of $9.46 million.
Analysts on Wall Street have shared their predictions regarding the annual performance of the company, estimating a total revenue of $36.6 million. Additionally, they are expecting the company to achieve per share loss of $1.39 for the fiscal year.
The per-share loss of $1.64 was highlighted in the company's earnings report for the same quarter of the prior year. This notable figure was achieved due to the company's impressive total revenue of $7.4 million recorded during that specific period.
In addition, The firm will review the third quarter financial results on 31st October 2024 at 08:00 AM eastern time, in a conference call with public.
Tuesday's trading saw Agios Pharmaceuticals (AGIO) shares hit a low of $45.80 and a high of $46.99, with a day volume of 286.80 thousand shares. The stock closed the regular trading session at $46.83, marking 1.63 percent rise.
